Pharmaceutical Sciences Master  |
 Kernfächer I |
| Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
|---|
| 535-0030-00L | Therapeutic Proteins | O | 3 KP | 3G | C. Halin Winter,
D. Neri |
| 535-0041-00L | Pharmacology and Toxicology III | O | 2 KP | 2G | M. Detmar,
U. Quitterer |
| 535-0050-00L | Pharmacoepidemiology and Drug Safety | O | 3 KP | 2G | S. Russmann,
A. Burden |
| 535-0546-00L | Patents | O | 1 KP | 1V | A. Koepf,
P. Pliska |
| 511-0000-00L | Drug Discovery and Development  Only for Pharmaceutical Sciences MSc. | O | 2 KP | 2G | U. Thibaut,
J. Hall |
| 511-0007-00L | Scientific Writing and Presenting Only for Pharmaceutical Sciences MSc. | O | 2 KP | 2G | G. Schneider,
J. Dolenc,
J. A. Hiss,
J.‑C. Leroux,
O. Renn,
J. Schnabl |
|
| Wahlfächer I |
| Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
|---|
| 535-0011-00L | Drug Seminar Die Belegung dieser Lerneinheit ist nur für Studierende möglich, die im Master Pharmazie oder im Master Pharmaceutical Sciences eingeschrieben sind. | W | 5 KP | 9S | U. Quitterer,
K.‑H. Altmann,
S. M. Ametamey,
A. Burden,
M. Detmar,
B. A. Gander,
C. Halin Winter,
J. Hall,
S.‑D. Krämer,
J.‑C. Leroux,
C. Müller,
D. Neri,
V. I. Otto,
R. Schibli,
G. Schneider,
C. Steuer |
| 511-1001-00L | Biopharmacy (Crash Course) Only for Pharmaceutical Sciences MSc.
Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | S.‑D. Krämer |
| 511-1002-00L | Pharmaceutical Analytics and Pharmacopeia (Crash Course) Only for Pharmaceutical Sciences MSc.
Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | C. Steuer |
| 511-1003-00L | Gene Technology (Crash Course) Only for Pharmaceutical Sciences MSc.
Obligatory course if assigned by the Admission committee. | E- | 1 KP | 1S | J. Scheuermann |
| 535-0423-00L | Drug Delivery and Drug Targeting | W | 2 KP | 1.5V | J.‑C. Leroux,
B. A. Gander,
A. Spyrogianni Roveri |
| 535-0250-00L | Biotransformation of Drugs and Xenobiotics | W | 1 KP | 1V | S.‑D. Krämer |
| 535-0015-00L | Geschichte der Pharmazie | W | 1 KP | 1V | M. Fankhauser |
| 535-0344-00L | Von Ethnopharmazie zu molekularer Pharmakognosie | W | 1 KP | 1V | B. Frei Haller,
J. Gertsch |
| 535-0310-00L | Glycobiology in Drug Development | W | 1 KP | 1V | V. I. Otto |
| 535-0300-00L | Molecular Mechanisms of Drug Actions and Targets Maximale Teilnehmerzahl: 24 | W | 2 KP | 1V | J. Scheuermann |
| 535-0021-00L | Vitamine in der Vorsorge und Therapie | W | 1 KP | 1V | C. Müller |
| 535-0360-00L | Rationale Phytotherapie an ausgewählten Beispielen | W | 1 KP | 1V | J. Drewe,
K. Berger Büter |
| 535-0137-00L | Clinical Chemistry II | W | 1 KP | 1V | M. Hersberger |
| 535-0022-00L | Computer-Assisted Drug Design | W | 1 KP | 1V | G. Schneider |
Seite
1
von
2
Alle